Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.58% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Lifezone Metals
LZM
$312M
| $1.42M | ﹤0.01% |
366,246
+247,093
| +207% | +$1.15M |
2025 Q4
2 quarters
|
|
2152
Sundial Growers
SNDL
$317M
| $1.42M | ﹤0.01% |
1,051,792
+449,567
| +75% | +$644K |
2026 Q1
1 quarter
|
|
2153
Rithm Capital
RITM
$5.24B
| $1.42M | ﹤0.01% |
+150,805
| New | +$1.44M |
2026 Q2
0 quarters
|
|
2154
Peoples Bancorp of North Carolina
PEBK
$231M
| $1.41M | ﹤0.01% |
32,807
-4,807
| -13% | -$200K |
2017 Q2
36 quarters
|
|
2155
Pebblebrook Hotel Trust
PEB
$2.3B
| $1.41M | ﹤0.01% |
+72,800
| New | +$1.12M |
2026 Q2
0 quarters
|
|
2156
Crocs
CROX
$5.72B
| $1.41M | ﹤0.01% |
+11,700
| New | +$1.28M |
2026 Q2
0 quarters
|
|
2157
Entrada Therapeutics
TRDA
$172M
| $1.41M | ﹤0.01% |
191,000
-11,084
| -5% | -$106K |
2024 Q2
8 quarters
|
|
2158
HUTCHMED
HCM
$2.5B
| $1.4M | ﹤0.01% |
130,200
-1,862
| -1% | -$23.5K |
2022 Q2
16 quarters
|
|
2159
Dimensional US Large Cap Value ETF
DFLV
$7.22B
| $1.4M | ﹤0.01% |
35,400
-39,500
| -53% | -$1.51M |
2026 Q1
1 quarter
|
|
2160
Dimensional US Core Equity Market ETF
DFAU
$12.8B
| $1.4M | ﹤0.01% |
+27,000
| New | +$1.35M |
2026 Q2
0 quarters
|
|
2161
Akebia Therapeutics
AKBA
$157M
| $1.4M | ﹤0.01% |
1,223,963
-609,165
| -33% | -$725K |
2020 Q2
24 quarters
|
|
2162
Flanigan's Enterprises
BDL
$90.7M
| $1.39M | ﹤0.01% |
30,993
-500
| -2% | -$17.2K |
2013 Q2
52 quarters
|
|
2163
Hawthorn Bancshares
HWBK
$287M
| $1.39M | ﹤0.01% |
35,319
+476
| +1% | +$17.1K |
2024 Q1
9 quarters
|
|
2164
Septerna Inc
SEPN
$1.89B
| $1.39M | ﹤0.01% |
41,419
+3,719
| +10% | +$106K |
2026 Q1
1 quarter
|
|
2165
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$242M
| $1.39M | ﹤0.01% |
+45,100
| New | +$1.65M |
2026 Q2
0 quarters
|
|
2166
ProShares Ultra Bitcoin ETF
BITU
$559M
| $1.38M | ﹤0.01% |
+170,300
| New | +$2.17M |
2026 Q2
0 quarters
|
|
2167
iShares U.S. Thematic Rotation Active ETF
THRO
$7.33B
| $1.37M | ﹤0.01% |
31,708
-3,892
| -11% | -$161K |
2025 Q2
4 quarters
|
|
2168
Metropolitan Bank Holding Corp
MCB
$1.2B
| $1.36M | ﹤0.01% |
13,800
+1,400
| +11% | +$127K |
2026 Q1
1 quarter
|
|
2169
Fidelity High Dividend ETF
FDVV
$10.4B
| $1.36M | ﹤0.01% |
+22,600
| New | +$1.34M |
2026 Q2
0 quarters
|
|
2170
Acrivon Therapeutics
ACRV
$74.1M
| $1.35M | ﹤0.01% |
758,863
+423
| +0.1% | +$719 |
2024 Q1
9 quarters
|
|
2171
Vanguard ESG US Stock ETF
ESGV
$13.3B
| $1.35M | ﹤0.01% |
+10,200
| New | +$1.3M |
2026 Q2
0 quarters
|
|
2172
Dan IVES Wedbush AI Revolution ETF
IVES
$1.03B
| $1.35M | ﹤0.01% |
+35,384
| New | +$1.25M |
2026 Q2
0 quarters
|
|
2173
Aura Minerals Inc
AUGO
$6.55B
| $1.35M | ﹤0.01% |
21,729
+15,487
| +248% | +$1.22M |
2025 Q3
3 quarters
|
|
2174
Innventure Inc
INV
$27.5M
| $1.35M | ﹤0.01% |
265,557
+160,557
| +153% | +$944K |
2025 Q4
2 quarters
|
|
2175
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
| $1.34M | ﹤0.01% |
6,800
-9,100
| -57% | -$1.76M |
2025 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.